85% Off Proven Crypto Timing Model - This Weekend Only!
Juan Villaverde's crypto timing model has called every major market turn since 2012. It's now signaling the next big move, and he believes these coins could have big upside. With the market at a critical moment, you can access his latest signals this weekend for just $19.
Indigenous groups get the spotlight at UN climate talks, but some say visibility isn't power
BELEM, Brazil (AP) — Indigenous people are used to adapting, so when the power failed at their kickoff event at this year's , they rolled with it. Participants from around the world sweated through song, dance and prayers, improvising without microphones and cooling themselves with fans made of paper or leaves.
Analyst Sees Strong Medtronic Momentum Through 2026 With Buy Rating Intact
BofA expects Medtronic to post over 5% second-quarter revenue growth and maintain strong momentum through 2026, driven by robust procedure trends.
$270,000 Drug. One Competitor. Billion-Dollar Market. - Ad
Phase 3 trial targets recurrent pericarditis with an oral therapy that could disrupt the only approved treatment. And their heart failure program launches in 2026.
Why Is Scholar Rock Holding Stock Climbing Today?
Scholar Rock shares jump after the company strengthened its cash runway into 2027 and advanced launch preparations for its lead drug candidate, apitegromab.
What is mutual aid? And why are more people turning to informal efforts to help each other?
When major disruptions happen in communities, often the first people to respond are the residents themselves and their neighbors. When the or after or wildfire, people get together to take care of each other.
The Smart Money Copper Trade - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
Here's what to know about the federal ban threatening the market for THC-infused drinks and snacks
MINNEAPOLIS (AP) — The production lines at Indeed Brewing moved quickly, the cans filling not with beer, but with THC-infused seltzer. The product, which features the compound that gets cannabis users high, has been a lifeline at Indeed and other craft breweries as in recent years.
Baxter Warns Of Potential Device Tampering In Life2000 Ventilator Recall
Baxter recalls its Life2000 ventilators after a cybersecurity flaw prompts an FDA high-risk alert, urging patients to stop use and seek replacement options.
Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad
AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.
Trump Says He Doesn't Want To Extend Obamacare Subsidies At All, But Concedes Measures May Be Taken To 'Get Something Else Done'
Trump rejects two-year ACA subsidy extension plan, despite reports of circulated draft framework. White House exploring options to prevent premium hikes.
Sanofi Faces Surprise HQ Search As French Authorities Expand Tax Probe
Sanofi faces a surprise tax probe in France as Dupixent secures EU approval for treating chronic spontaneous urticaria.
Is Big Pharma's Next Target Already in Play? - Ad
A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.
The Miami Project to Cure Paralysis follows science and steady funding to a broader mission
Marc Buoniconti said his father, , explained the secret to the success of their nonprofit and its fundraising efforts simply: “We’re just not good listeners.”
Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study
Bayer's asundexian cut ischemic stroke risk without more bleeding, boosting FXIa optimism while raising fresh questions for Bristol Myers' milvexian program.
Cyber Weekend Sale! 85% Off Disruptors and Dominators! - Ad
Nvidia's robot breakthrough, unveiled by CEO Jensen Huang at CES, could spark a $24T revolution. He said the "ChatGPT moment" for robotics is near. I believe the lives of 65M Americans could be impacted - this year. And one $7 stock could be the biggest winner.
Trump Officials Retreat On Social Security Disability Rule After Advocates Sound Alarm
Trump administration drops rule to make it harder for older Americans to qualify for Social Security disability benefits after criticism.
Plan for $20 million firefighter training center near the site of Ohio derailment revived
Norfolk Southern railroad worked with the state of Ohio and Youngstown State University to revive plans for a $20 million first responder training center near the site of the in East Palestine, Ohio.
85% Off Proven Crypto Timing Model - This Weekend Only! - Ad
Juan Villaverde's crypto timing model has called every major market turn since 2012. It's now signaling the next big move, and he believes these coins could have big upside. With the market at a critical moment, you can access his latest signals this weekend for just $19.
At UN climate conference, some activists and scientists want more talk on reforming agriculture
BELEM, Brazil (AP) — With a spotlight on the Brazilian Amazon, where agriculture drives a significant chunk of deforestation and planet-warming emissions, many of the activists, scientists and government leaders at United Nations climate talks have a beef. They want more to be done to transform the world's food system.
Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat
Vanda's tradipitant cut Wegovy-related vomiting by 50% in a new trial, prompting bullish analyst views and price targets.
85% Off: Unlock the 5 gold stocks that could surge - Ad
Gold pushed past $4,200, but our expert Sean Brodrick says the real opportunity could lie in a handful of stocks that may soar far beyond gold. He believes the biggest bull market is taking shape and thinks these five companies may have major upside. This weekend only, you can get all five names for just $19.
What Sparked PACS Group Stock Jumped Over 45% In After-Hours Trading?
PACS Group shares surged in after-hours trading following strong third -quarter results and the completion of financial restatements.
As infant botulism cases climb to 31, recalled ByHeart baby formula is still on some store shelves
As cases of potentially deadly botulism in babies who drank ByHeart infant formula continue to grow, state officials say they are still finding the on some store shelves.
Copper, Silver, Gold, Tungsten - This Nevada Play Offers Multiple Shots on Goal - Ad
Most early-stage resource opportunities rely on one metal. This one doesn't. The Walker Lane belt hosts copper, silver, gold, and tungsten - and recent results across the district confirm all four. This startup has stepped in with multi-metal exposure, giving investors several potential ways to capture upside.
Why Did Nutex Health's (NUTX) Shares Soar 21% After Hours?
Nutex Health's shares jumped nearly 21% in after-hours trading following strong second-quarter results and a new $25 million stock buyback program.
Major Victory For Genmab As Epkinly Receives FDA Approval For Type Of Pretreated Blood Cancer
Genmab's Epkinly receives traditional FDA approval for relapsed or refractory follicular lymphoma in combination and monotherapy. Clinical trial data show superior results.
A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad
Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.
Nuvalent Reports 31% Response Rate In Patients With Advanced Form Of Lung Cancer
Nuvalent reports durable neladalkib responses in pretreated and TKI-naïve ALK-positive NSCLC, with strong rates in the ALKOVE-1 trial.
AP Lifestyles Digest for week of Nov. 17
Here is the AP Lifestyles Digest for the week of Nov. 17. Note AP's Holiday Gift Guide Digest moved Nov. 12 and is included at the end.
Urgent Copper Stock With Strong Catalysts - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
WASHINGTON (AP) — The Food and Drug Administration said Friday it will add a new warning and other limitations to a that's been linked to .
Cartesian Pauses Lupus And Multiple Myeloma Studies As It Shifts Development Focus
Cartesian Therapeutics shared initial data from Phase 2 trial of Descartes-08, showing potential for treating systemic lupus erythematosus.
$270,000 Drug. One Competitor. Billion-Dollar Market. - Ad
Phase 3 trial targets recurrent pericarditis with an oral therapy that could disrupt the only approved treatment. And their heart failure program launches in 2026.
Applied Therapeutics Tanks As FDA Path For Lead Rare-Disease Drug Turns Uncertain
Applied Therapeutics stock falls after FDA feedback prompts another Type C meeting to discuss the Phase 3 plan for its CMT-SORD drug govorestat.
Workers take on side jobs to combat stagnant salaries and insecurity about employment
NEW YORK (AP) — As workers face , inflation and , some have decided to branch out from their traditional careers. They're taking on side jobs to bring in additional income and provide a backup plan should they , or adding second, third and sometimes fourth jobs — what some call “polyworking” — to the mix.
The Smart Money Copper Trade - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
2 new malaria treatments announced as drug resistance grows
NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs.
This Undervalued Biotech Might Have Just Proven Its Star Drug's Staying Power
Apellis reports five-year Syfovre data showing up to 31% slower GA lesion growth, reinforcing strong long-term efficacy and analyst optimism.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.